Towards a better understanding of kidney cancer: genetically engineered mouse models and biomarkers insights
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · 2026-09 · 1881 (4) · 189596
DOI: 10.1016/j.bbcan.2026.189596 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Biochimica et Biophysica Acta (BBA) - Reviews on Cancer, 2026-09. Verfasst von Laurie De Castro und 3 weiteren Autor:innen. Beteiligte Einrichtung: Autorité de Sûreté Nucléaire et de Radioprotection (ASNR), PSE-SANTE/SESANE, Fontenay aux Roses Cedex, France. Hauptthemen laut MEDLINE: Kidney Neoplasms, Biomarkers, Tumor, Carcinoma, Renal Cell. Die Arbeit nennt 123 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Kidney cancer has been rising steadily for over 30 years, especially in Western countries. Risk factors include lifestyle habits, comorbid conditions, genetic predispositions, and occupational or environmental exposures. There is a need for expanded research to elucidate the principal etiological determinants of this malignancy and develop new treatments. This review brings together the essential knowledge to design an experimental study on renal carcinogenesis. Thus, we review the available mouse models and relevant renal tumor markers in mice, including methods from histological and molecular analyses to in-vivo small animal imaging. Genetically engineered mouse models can closely reproduce the different types of human renal cell carcinoma, both morphologically and functionally. This work presents a selection of highly specific kidney cancer models with high translational relevance in preclinical research. Similarly, a systematic bibliographic search was performed in Scopus to select experimental studies in rodents that used biomarkers to assess kidney cancer. Finally, the third section of this review follows the same process to retrieve experimental studies in rodent that used biomarkers to assess kidney cancer and allowed the identification of over 130 different markers.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Autorité de Sûreté Nucléaire et de Radioprotection (ASNR), PSE-SANTE/SESANE, Fontenay aux Roses Cedex, France.
- Autorité de Sûreté Nucléaire et de Radioprotection (ASNR), PSE-SANTE/SESANE, Fontenay aux Roses Cedex, France; Institut Necker Enfants Malades (INEM) / INSERM U 1151- CNRS UMR 8253, Université Paris Cité, France.
- Université Paris-Saclay, Gustave Roussy, CNRS, UMR 9019, Intégrité du Génome et Cancer, Villejuif, France; Ecole Pratique des Hautes Etudes (EPHE), Université Paris Sciences Lettres (PSL), Paris, France.
- Autorité de Sûreté Nucléaire et de Radioprotection (ASNR), PSE-SANTE/SESANE, Fontenay aux Roses Cedex, France. Electronic address: yann.gueguen@asnr.fr.
Zitieren
APA
De Castro, L., Claude, O., Gad, S., & Guéguen, Y. (2026). Towards a better understanding of kidney cancer: genetically engineered mouse models and biomarkers insights. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer, 1881(4), 189596. https://doi.org/10.1016/j.bbcan.2026.189596
Vancouver
De Castro L, Claude O, Gad S, Guéguen Y. Towards a better understanding of kidney cancer: genetically engineered mouse models and biomarkers insights. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer. 2026;1881(4):189596. doi:10.1016/j.bbcan.2026.189596
BibTeX
@article{DeCastro2026,
author = {De Castro, Laurie and Claude, Olivier and Gad, Sophie and Guéguen, Yann},
title = {Towards a better understanding of kidney cancer: genetically engineered mouse models and biomarkers insights},
journal = {Biochimica et Biophysica Acta (BBA) - Reviews on Cancer},
year = {2026},
volume = {1881},
number = {4},
pages = {189596},
doi = {10.1016/j.bbcan.2026.189596}
}
EUVIMED